Company Number: 14098701

Analysis Date: 2025-07-29 14:23 UTC

Financial Health Assessment for EasyLee Ltd as of 31 March 2024

---

1. Financial Health Score: D

Explanation:
EasyLee Ltd shows significant signs of financial distress as of the latest financial year. The company has moved from a previously strong net asset position to a substantial net liability state, indicating unhealthy financial "vital signs." This score reflects the urgent need for remedial action to restore financial stability.

---

2. Key Vital Signs

Metric	2024 Value	2023 Value	Interpretation
Net Current Assets (Working Capital)	£-42,226	£41,950	A severe negative working capital indicates liquidity problems — the company cannot cover short-term debts with current assets ("symptom of cash flow distress").
Net Assets (Equity)	£-15,501	£57,325	Negative equity means the company owes more than it owns — a “critical symptom” of insolvency risk.
Current Liabilities	£43,441	£0	Sharp increase in immediate debts without matching asset increase signals financial strain.
Cash on Hand	£365	£464	Very low cash reserves limit ability to meet urgent obligations — “weak pulse” of liquidity.
Intangible Assets (Net)	£27,250	£40,875	Asset amortisation reduces value, but these assets are illiquid and cannot be used for immediate cash needs.
Shareholders’ Funds	£-15,501	£57,325	Reflects cumulative losses eroding owner’s investment — “sign of internal financial bleeding.”

Additional Observations:

• The company operates as a micro to small private limited company with one director who is also the sole significant controller.
• The company has no audit exemption issues and timely files accounts and returns.
• The going concern assumption is declared by the director, but the financial data contradicts the stability implied by this assumption.

---

3. Diagnosis: Financial Condition Assessment

EasyLee Ltd is currently exhibiting symptoms of severe financial distress, akin to a patient who has suddenly lost vital organ function. The dramatic swing from a strong net asset and working capital position in 2023 to substantial net liabilities and negative working capital in 2024 suggests a liquidity crisis and potential solvency issues.

The primary “symptom” is the enormous current liabilities (£43,441) compared to minuscule current assets (£1,215), meaning the company is unable to meet short-term debts from readily available resources. This “unhealthy cash flow” situation could lead to creditor pressure, default risk, and jeopardizes operational continuity.

The intangible assets have been amortised, reducing their book value, but these are not liquid and cannot be quickly converted to cash to relieve immediate financial pressure.

Overall, the company’s “financial health” is poor, with urgent intervention required to avoid insolvency or forced liquidation.

---

4. Recommendations for Financial Wellness Improvement

Immediate Actions:

• Cash Flow Management: Develop a rigorous cash flow forecast and prioritize collection of debtors. Consider negotiating extended payment terms with creditors to ease immediate liquidity pressures.
• Cost Control: Review and reduce discretionary expenses to preserve cash.
• Capital Injection: The sole shareholder/director may need to inject new equity or arrange for short-term financing to restore positive working capital.
• Asset Review: Evaluate intangible assets for impairment and consider whether some non-core assets can be sold to raise cash.
• Engage Professionals: Consult with a financial advisor or insolvency practitioner for restructuring options before distress worsens.

Medium to Long-term Actions:

• Revenue Enhancement: Focus on sustainable income growth to rebuild retained earnings.
• Debt Restructuring: Negotiate with creditors to restructure debts, possibly converting some into longer-term liabilities.
• Financial Reporting: Implement improved internal financial controls and regular management reporting to monitor “vital signs” closely.

---

Medical Analogy Summary:
EasyLee Ltd is like a patient who has experienced a sudden collapse in vital signs—liquidity and equity. The current clinical picture shows “symptoms of distress” with negative working capital and net liabilities. Without immediate “treatment” through cash flow improvement and capital support, the prognosis is poor, risking the company’s survival.

---